Dargo Bio

Dargo Bio

达歌生物

Dargo Bio

Biotech/Healthcare

Dage Biotech develops molecular glue-based targeted protein degradation technologies and novel therapeutics. Starting from a new chemical scaffold discovered by Professor Cang Yong's laboratory, the company has built a proprietary compound library distinct from the lenalidomide- and…

Latest round: Series A Extension+ (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-05-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.